Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis
Sarah E. Stansfield(Fred Hutch Cancer Center), Dobromir Dimitrov(Fred Hutch Cancer Center), Ruanne V. Barnabas(University of Washington), Gesine Meyer‐Rath(University of the Witwatersrand), Marie‐Claude Boily(Imperial College London), Lise Jamieson(National Research Foundation), Loveleen Bansi‐Matharu, Leigh F. Johnson(University of Cape Town), David Kaftan(New York University Florence), Jennifer S. Smith(University College London), Anna Bershteyn(New York University), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mia Moore(Fred Hutch Cancer Center), Andrew Phillips(University College London), Jesse Heitner(Harvard University), Valentina Cambiano(University College London)
Cited by 3
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Global epidemiology of HIV among female sex workers: influence of structural determinants
|The Lancet|2014|884
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2015|638